
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy
Keywords: cccDNA; Chronic hepatitis B; HBcrAg; HBsAg; Hepatitis B core-related antigen; Hepatitis B virus; Pegylated interferon; Predictor; Stopping rule; Treatment response;